论文部分内容阅读
目的探究介入血管内栓塞治疗大咯血的应用方法,观察患者临床疗效,评估介入血管内栓塞的临床意义。方法以我院收治的43例大咯血患者作为研究对象,统一实施介入血管内栓塞治疗方案,患者于介入血管内栓塞治疗后若无出血且3个月内无出血现象定为显效;患者出血量于术后甚小,加之3个月内无出血现象定为有效。结果 43例患者中,仅有6例于首次介入血管内栓塞治疗第一周内再次引发大咯血,出血状况于第二次介入治疗后方停止。所有患者的出血于3个月内均无复发,总有效率100%。尚未出现严重的不良反应,并发症发生率34.88%。结论介入血管内栓塞治疗大咯血可获取确切疗效,可靠性与安全性均高,值得推广使用。
Objective To explore the application of endovascular embolization in the treatment of massive hemoptysis, to observe the clinical efficacy and evaluate the clinical significance of interventional endovascular embolization. Methods A total of 43 patients with massive hemoptysis admitted to our hospital were enrolled in this study. The patients were treated with endovascular embolization without intervention, and no bleeding was found within 3 months after the endovascular embolization. The patient’s bleeding volume Very small after surgery, combined with no bleeding within 3 months as valid. Results Of the 43 patients, only 6 of the 43 patients had re-induced hemoptysis in the first week after the first interventional endovascular embolization. Bleeding stopped after the second intervention. All patients had no recurrence of hemorrhage within 3 months, with a total effective rate of 100%. No serious adverse reactions have yet occurred, the complication rate is 34.88%. Conclusion Interventional endovascular treatment of massive hemoptysis can obtain the exact effect, reliability and safety are high, it is worth promoting the use of.